- Home
- CDIO vs MSPR Comparison
CDIO vs MSPR Comparison
Compare CDIO & MSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- MSPR
- Stock Information
- Founded
- CDIO 2017
- MSPR 2014
- Country
- CDIO United States
- MSPR United States
- Employees
- CDIO N/A
- MSPR N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- MSPR
- Sector
- CDIO Health Care
- MSPR
- Exchange
- CDIO Nasdaq
- MSPR NYSE
- Market Cap
- CDIO 7.0M
- MSPR 7.8M
- IPO Year
- CDIO N/A
- MSPR N/A
- Fundamental
- Price
- CDIO $4.77
- MSPR $1.42
- Analyst Decision
- CDIO Buy
- MSPR
- Analyst Count
- CDIO 1
- MSPR 0
- Target Price
- CDIO $60.00
- MSPR N/A
- AVG Volume (30 Days)
- CDIO 102.5K
- MSPR 66.4K
- Earning Date
- CDIO 05-15-2025
- MSPR 05-15-2025
- Dividend Yield
- CDIO N/A
- MSPR N/A
- EPS Growth
- CDIO N/A
- MSPR N/A
- EPS
- CDIO N/A
- MSPR N/A
- Revenue
- CDIO $19,902.00
- MSPR $13,085,000.00
- Revenue This Year
- CDIO $1,434.82
- MSPR N/A
- Revenue Next Year
- CDIO $4,661.91
- MSPR N/A
- P/E Ratio
- CDIO N/A
- MSPR N/A
- Revenue Growth
- CDIO N/A
- MSPR 34.74
- 52 Week Low
- CDIO $3.40
- MSPR $1.10
- 52 Week High
- CDIO $53.10
- MSPR $17.88
- Technical
- Relative Strength Index (RSI)
- CDIO 39.92
- MSPR N/A
- Support Level
- CDIO $3.88
- MSPR N/A
- Resistance Level
- CDIO $5.20
- MSPR N/A
- Average True Range (ATR)
- CDIO 0.48
- MSPR 0.00
- MACD
- CDIO 0.32
- MSPR 0.00
- Stochastic Oscillator
- CDIO 68.25
- MSPR 0.00
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About MSPR MSP RECOVERY INC
MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.